{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T06:23:13Z","timestamp":1787638993828,"version":"build-2736575974"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Neonatal hypoxic-ischemic encephalopathy (HIE) is a major cause of neonatal death and long-term neurological disability. Early recognition of high-risk neonates remains difficult because clinical examination, imaging, electrophysiology, and biochemical tests may be limited by timing, access, or early sensitivity. We aimed to identify and clinically validate a peripheral blood biomarker candidate for HIE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Public transcriptomic datasets related to neonatal HIE or experimental hypoxic-ischemic injury were analyzed as separate biological resources. The human whole-blood dataset served as the primary discovery dataset. Experimental rat cortex datasets were analyzed separately and used only as supportive context after ortholog mapping. Candidate prioritization considered nominal human blood evidence, directionally concordant supportive transcriptomic signals, HIE-related disease-gene annotation, and validation in human peripheral blood mononuclear cells (PBMCs). F3 mRNA was measured by qRT-PCR, and full-length tissue factor (flTF) protein was assessed by immunofluorescence and Western blotting in an independent cohort of neonates with HIE (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200940) and non-HIE controls (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200930).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      With an exploratory nominal screening threshold, dataset-specific analysis identified F3 as a candidate gene with nominal upregulation in the human whole-blood dataset (log2FC\u2009=\u20096.27, nominal\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.041, adjusted\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.524). Independent experimental hypoxic-ischemic injury datasets showed directionally concordant supportive signals. In the clinical cohort, PBMC F3 mRNA was higher in neonates with HIE than in non-HIE controls (4.2\u2009\u00b1\u20090.2 vs. 1.0\u2009\u00b1\u20090.1,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.0001), with increased flTF protein expression. ROC analysis showed good discrimination in this cohort (AUC, 0.844; 95% CI, 0.735\u20130.953).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>F3\/flTF was prioritized as an exploratory peripheral blood biomarker candidate on the basis of nominal human whole-blood transcriptomic evidence, supportive disease-model data, HIE-related disease-gene annotation, and independent PBMC validation. PBMC F3\/flTF may help identify HIE and stratify risk, but larger human blood cohorts, confounder-adjusted analyses, and mechanistic studies are needed before clinical use can be considered.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1891438","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:35:56Z","timestamp":1787636156000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification and clinical validation of F3 as a peripheral blood biomarker for neonatal hypoxic-ischemic encephalopathy using dataset-specific bioinformatics analysis"],"prefix":"10.3389","volume":"14","author":[{"given":"Suxiang","family":"Pan","sequence":"first","affiliation":[{"name":"Department of Neonatal Intensive Care Unit, Affiliated Hospital of Putian University","place":["Putian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, First People\u2019s Hospital of Wuhu","place":["Wuhu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqing","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Neonatal Intensive Care Unit, Affiliated Hospital of Putian University","place":["Putian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Neonatal Intensive Care Unit, Affiliated Hospital of Putian University","place":["Putian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neonatal Intensive Care Unit, Affiliated Hospital of Putian University","place":["Putian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijuan","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Neonatal Intensive Care Unit, Affiliated Hospital of Putian University","place":["Putian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1161\/STROKEAHA.125.051107","article-title":"Diminished cerebral oxygen extraction and metabolic rate in neonates with hypoxic ischemic encephalopathy","volume":"56","author":"Jiang","year":"2025","journal-title":"Stroke"},{"key":"B2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3390\/biomedicines10020347","article-title":"Pathophysiology of perinatal asphyxia in humans and animal models","volume":"10","author":"Mota-Rojas","year":"2022","journal-title":"Biomedicines"},{"key":"B3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.earlhumdev.2010.05.010","article-title":"Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy","volume":"86","author":"Kurinczuk","year":"2010","journal-title":"Early Hum Dev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1038\/s41390-025-03986-2","article-title":"Neonatal encephalopathy and hypoxic-ischemic encephalopathy: the state of the art","volume":"98","author":"Chakkarapani","year":"2025","journal-title":"Pediatr Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jpeds.2009.03.040","article-title":"Clinical neonatal seizures are independently associated with outcome in infants at risk for hypoxic-ischemic brain injury","volume":"155","author":"Glass","year":"2009","journal-title":"J Pediatr"},{"key":"B6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/MOP.0000000000000591","article-title":"Blood biomarkers for evaluation of perinatal encephalopathy: state of the art","volume":"30","author":"Graham","year":"2018","journal-title":"Curr Opin Pediatr"},{"key":"B7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jpeds.2017.10.060","article-title":"Plasma biomarkers of brain injury in neonatal hypoxic-ischemic encephalopathy","volume":"194","author":"Massaro","year":"2018","journal-title":"J Pediatr"},{"key":"B8","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jpeds.2022.07.046","article-title":"Plasma biomarkers of evolving encephalopathy and brain injury in neonates with hypoxic-ischemic encephalopathy","volume":"252","author":"Li","year":"2023","journal-title":"J Pediatr"},{"key":"B9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/B978-0-444-64029-1.00013-8","article-title":"Biomarkers in neonatal hypoxic-ischemic encephalopathy-review of the literature to date and future directions for research","volume":"162","author":"Murray","year":"2019","journal-title":"Handb Clin Neurol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13052-020-00822-7","article-title":"Identification of novel biomarkers for neonatal hypoxic-ischemic encephalopathy using iTRAQ","volume":"46","author":"Zhu","year":"2020","journal-title":"Ital J Pediatr"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1007\/s12035-024-04398-9","article-title":"Hypoxic-Ischemic encephalopathy: pathogenesis and promising therapies","volume":"62","author":"Yang","year":"2025","journal-title":"Mol Neurobiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"8499","DOI":"10.1002\/jcb.28138","article-title":"Analysis of long noncoding RNA expression profiles in the whole blood of neonates with hypoxic-ischemic encephalopathy","volume":"120","author":"Dong","year":"2019","journal-title":"J Cell Biochem"},{"key":"B13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3892\/mmr.2020.11091","article-title":"Expression profile of circular RNAs in the peripheral blood of neonates with hypoxic-ischemic encephalopathy","volume":"22","author":"Dong","year":"2020","journal-title":"Mol Med Rep"},{"key":"B14","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s12031-010-9337-x","article-title":"Gene network analysis to determine the effects of antioxidant treatment in a rat model of neonatal hypoxic-ischemic encephalopathy","volume":"42","author":"Kojima","year":"2010","journal-title":"J Mol Neurosci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s12031-012-9830-5","article-title":"Comprehensive gene expression analysis of cerebral cortices from mature rats after neonatal hypoxic-ischemic brain injury","volume":"49","author":"Kojima","year":"2013","journal-title":"J Mol Neurosci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"bbae515","DOI":"10.1093\/bib\/bbae515","article-title":"Thinking points for effective batch correction on biomedical data","volume":"25","author":"Hui","year":"2024","journal-title":"Brief Bioinform"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1161\/ATVBAHA.108.177402","article-title":"Tissue factor in coagulation: which? Where? When?","volume":"29","author":"Butenas","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.tcm.2015.12.001","article-title":"Tissue factor as a link between inflammation and coagulation","volume":"26","author":"Witkowski","year":"2016","journal-title":"Trends Cardiovasc Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/1471-2431-14-277","article-title":"Coagulopathy in newborns with hypoxic ischemic encephalopathy treated with therapeutic hypothermia: a retrospective case-control study","volume":"14","author":"Forman","year":"2014","journal-title":"BMC Pediatr"},{"key":"B20","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1001\/archneur.1976.00500100030012","article-title":"Neonatal encephalopathy following fetal distress: a clinical and electroencephalographic study","volume":"33","author":"Sarnat","year":"1976","journal-title":"Arch Neurol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"507","DOI":"10.5152\/TurkArchPediatr.2025.25126","article-title":"Challenging mild hypoxic-ischemic encephalopathy: insights into neurological outcomes","volume":"60","author":"Canbeldek","year":"2025","journal-title":"Turk Arch Pediatr"},{"key":"B22","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3390\/diagnostics11050897","article-title":"Identifying early diagnostic biomarkers associated with neonatal hypoxic-ischemic encephalopathy","volume":"11","author":"Lee","year":"2021","journal-title":"Diagnostics (Basel)"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1891438\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:35:57Z","timestamp":1787636157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1891438\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":22,"alternative-id":["10.3389\/fped.2026.1891438"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1891438","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"article-number":"1891438"}}